DNA nanotechnology provides cell-surface sensors for real-time monitoring of single cells, including potential use in personalized medicine to test which drugs would be suitable for which individuals.
DNA nanotechnology provides cell-surface sensors for real-time monitoring of single cells, including potential use in personalized medicine to test which drugs would be suitable for which individuals.
A nanotechnology therapy using targeted dendrimers shows promise against head and neck cancer in experiments in which human tumors are implanted into immunocompromised mice.
The world’s first synthetic organ transplant was a replica windpipe made from a nanocomposite scaffold seeded with the patient’s own adult stem cells.
Treatment of mice previously infected with a lethal dose of flu virus with a nanotechnology-based drug lowered viral load a thousand fold.
A biochemical circuit built from 74 small DNA molecules demonstrates an approach that may enable embedded control of molecular devices.
Carbon nanofibers and a polymer were combined to create a composite to regenerate natural heart tissue.
A poll of NewScientist readers selected medical nanorobots as the technology that will have the biggest impact on human life in the next 30 years.
Protein, RNA, DNA provide very different molecular architectures for nanotechnology to adopt to deliver drugs to cancer cells while sparing healthy cells.
‘Good Cholesterol’ nanoparticles are non-toxic and use the need of cancer cells for HDL cholesterol to deliver RNA molecules to silence the expression of cancer-promoting genes.
Porous silica nanoparticles covered with a lipid bilayer deliver large doses of drugs and kill cancer cells a million fold better than do simple liposomes.
